Kristen Lore, DO
Obstetrics & Gynecology · Asbury Park, NJNPI 1063770568
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 16 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 11 manufacturers, the largest accounting for just 23.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $92 and has fallen 84.7% since, to $14 in 2025. That places this record below the midpoint for obstetrics & gynecology clinicians in NJ, where the typical reported total is $534.
Across 16 payments — averaging $14.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lupin Inc.$54
- Smith+Nephew$27
- Davol Inc.$26
- Merck$24
- Mayne Pharma Commercial LLC$18
- Astellas Pharma US Inc$17
- plus $67 from 5 others
Across 36 payments — averaging $2281.46 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bayer$43K
- Ventana Medical Systems, Inc.$39K
What the payments were for
- Food & beverage$232100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lupin Inc. | 4 | $54 |
| Smith+Nephew | 2 | $27 |
| Davol Inc. | 1 | $26 |
| Merck | 2 | $24 |
| Mayne Pharma Commercial LLC | 1 | $18 |
| Astellas Pharma US Inc | 1 | $17 |
| Organon | 1 | $16 |
| Bayer | 1 | $14 |
| Evofem Biosciences, Inc. | 1 | $13 |
| Aspira Women's Health Inc | 1 | $12 |
| Coopersurgical, Inc. | 1 | $11 |
How this compares
$232 in reported general payments places this provider in the 30th percentile of 1,242 obstetrics & gynecology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 30 | $1,483 |
| Metronidazole | 17 | $282 |
| Clobetasol Propionate | 11 | $222 |
| Fluconazole | 17 | $95 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Asbury Park
- Jennifer AshtonEnglewood$1.5M
- Geoffrey BowersVoorhees$228K
- Neha DeshpandePlainsboro$206K
- Paula JasionowskiVoorhees$193K
- Justin ChuraSwedesboro$179K
- Andrea VentolaFlorham Park$145K
- Aiman ShiladPaterson$100K
- Patrick CulliganMorristown$93K
- Dipak DelvadiaCherry Hill$86K
- Susan PitmanWest Orange$77K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.